These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2644800)

  • 1. Efficacy of medical therapy tailored for severe congestive heart failure in patients transferred for urgent cardiac transplantation.
    Stevenson LW; Dracup KA; Tillisch JH
    Am J Cardiol; 1989 Feb; 63(7):461-4. PubMed ID: 2644800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early and medium term results of tailored therapy for heart failure.
    Martins S; Soares RM; do Rosário L; Quininha J; Antunes AM
    Rev Port Cardiol; 2001 Mar; 20(3):261-82. PubMed ID: 11417309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urgent priority transplantation: when should it be done?
    Stevenson LW; Donohue BC; Tillisch JH; Schulman B; Dracup KA; Laks H
    J Heart Transplant; 1987; 6(5):267-72. PubMed ID: 3316550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tailored therapy before transplantation for treatment of advanced heart failure: effective use of vasodilators and diuretics.
    Stevenson LW
    J Heart Lung Transplant; 1991; 10(3):468-76. PubMed ID: 1854776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute reduction of atrial overload during vasodilator and diuretic therapy in advanced congestive heart failure.
    Hamilton MA; Stevenson LW; Child JS; Moriguchi JD; Woo M
    Am J Cardiol; 1990 May; 65(18):1209-12. PubMed ID: 2186605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
    Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B
    Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of intravenous milrinone followed by titration of high-dose oral vasodilator therapy on clinical outcome and rehospitalization rates in patients with severe heart failure.
    Cusick DA; Pfeifer PB; Quigg RJ
    Am J Cardiol; 1998 Nov; 82(9):1060-5. PubMed ID: 9817482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic effects of intravenous digoxin in patients with severe heart failure initially treated with diuretics and vasodilators.
    Gheorghiade M; St Clair J; St Clair C; Beller GA
    J Am Coll Cardiol; 1987 Apr; 9(4):849-57. PubMed ID: 3558983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin E1--bridge to cardiac transplantation. Technique, dosage, results.
    Pacher R; Stanek B; Hülsmann M; Berger R; Siegel A; Daneschvar H; Rödler S; Frey B; Grimm M; Laufer G
    Eur Heart J; 1997 Feb; 18(2):318-29. PubMed ID: 9043849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic and neurohumoral effects of long-term prostaglandin E1 infusions in outpatients with severe congestive heart failure.
    Hülsmann M; Stanek B; Frey B; Berger R; Rödler S; Siegel A; Hartter E; Schuller M; Ogris E; Pacher R
    J Heart Lung Transplant; 1997 May; 16(5):556-62. PubMed ID: 9171275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained reduction in valvular regurgitation and atrial volumes with tailored vasodilator therapy in advanced congestive heart failure secondary to dilated (ischemic or idiopathic) cardiomyopathy.
    Hamilton MA; Stevenson LW; Child JS; Moriguchi JD; Walden J; Woo M
    Am J Cardiol; 1991 Feb; 67(4):259-63. PubMed ID: 1990789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise capacity for survivors of cardiac transplantation or sustained medical therapy for stable heart failure.
    Stevenson LW; Sietsema K; Tillisch JH; Lem V; Walden J; Kobashigawa JA; Moriguchi J
    Circulation; 1990 Jan; 81(1):78-85. PubMed ID: 2297851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in the treatment of congestive heart failure.
    Chen SC
    Indian J Pediatr; 1998; 65(1):13-20. PubMed ID: 10771942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure.
    Paterna S; Di Pasquale P; Parrinello G; Amato P; Cardinale A; Follone G; Giubilato A; Licata G
    Eur J Heart Fail; 2000 Sep; 2(3):305-13. PubMed ID: 10938493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of furosemide and metolazone in the treatment of severe congestive heart failure.
    Grosskopf I; Rabinovitz M; Rosenfeld JB
    Isr J Med Sci; 1986 Nov; 22(11):787-90. PubMed ID: 3793436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of end-stage heart failure is predicted by long-term therapeutic response rather than initial hemodynamic and neurohormonal profile.
    Levine TB; Levine AB; Goldberg D; Narins B; Goldstein S; Lesch M
    J Heart Lung Transplant; 1996 Mar; 15(3):297-303. PubMed ID: 8777214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic indices in heart transplant candidates after the first hospitalization triggered by the need for intravenous pharmacologic circulatory support.
    Gronda EG; Barbieri P; Frigerio M; Mangiavacchi M; Oliva F; Quaini E; Andreuzzi B; Garascia A; De Vita C; Pellegrini A
    J Heart Lung Transplant; 1999 Jul; 18(7):654-63. PubMed ID: 10452341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute congestive heart failure. The need for aggressive therapy.
    Levin TN
    Postgrad Med; 1997 Jan; 101(1):97-100, 103-4, 108-11. PubMed ID: 9008691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of afterload reduction (diuretics and vasodilators) on left ventricular volume and mitral regurgitation in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Stevenson LW; Bellil D; Grover-McKay M; Brunken RC; Schwaiger M; Tillisch JH; Schelbert HR
    Am J Cardiol; 1987 Sep; 60(8):654-8. PubMed ID: 3661430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplant candidates with severe left ventricular dysfunction managed with medical treatment: characteristics and survival.
    Rickenbacher PR; Trindade PT; Haywood GA; Vagelos RH; Schroeder JS; Willson K; Prikazsky L; Fowler MB
    J Am Coll Cardiol; 1996 Apr; 27(5):1192-7. PubMed ID: 8609341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.